휴젤은 보툴리눔 톡신 제제, 히알루론산 필러, 흡수성 봉합사, 클리니컬 더마 코스메틱을 제조 및 판매하는 글로벌 토탈 메디컬 에스테틱 전문 기업입니다. 휴젤은 대한민국을 뛰어넘어 전 세계인에게 건강과 아름다움을 제공하고 행복한 삶의 가치를 창출하기 위해 끊임없이 노력하고 있습니다.
| Website | https://www.hugel-inc.com/kr |
| Revenue | $239.43 million |
| Employees | 151 (55 on RocketReach) |
| Founded | 2001 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Medical Aesthetics, Botulinum Toxin, Aesthetic Medicine, Dermal Fillers, Medical Devices, Dermal Treatments, Cosmetic Injectables, Facial Rejuvenation, Absorbable Sutures, Pharmaceutical, Wrinkle Treatment, Surgical Sutures, Biotechnology, Non-Invasive Treatments, Cosmetics, Beauty Products, Health And Beauty, Anti-Aging, Skincare |
| Competitors | Revance, Actavis plc (now Allergan), Ipsen, Medytox, Galderma, Hugel Inc., Evolus, Sientra, Inc., Merz Group +37 more (view full list) |
Looking for a particular HUGEL employee's phone or email?
The HUGEL annual revenue was $239.43 million in 2026.
Daniel Chang is the CEO of HUGEL.
55 people are employed at HUGEL.